Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (471-480 of 535) with videos related to

Pageof 54
Sort By:
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Epidemiological and immunological features of obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
The Journal of Pediatrics|September 21, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Nature Communications|February 16, 2021
Discrete SARS-CoV-2 antibody titers track with functional humoral stabilityYannic C Bartsch, Stephanie Fischinger, Sameed M Siddiqui, et al.
Journal of Virology|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIV<sub>smE660</sub> Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesShakti Singh, Eric G Ramírez-Salazar, Rami Doueiri, et al.
The Journal of Pediatrics|September 24, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.
The Journal of Pediatrics|August 23, 2020
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune ResponsesLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Pageof 54

Showing results (471-480 of 535) with videos related to

Sort By:
Pageof 54
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Epidemiological and immunological features of obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
The Journal of Pediatrics|September 21, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Nature Communications|February 16, 2021
Discrete SARS-CoV-2 antibody titers track with functional humoral stabilityYannic C Bartsch, Stephanie Fischinger, Sameed M Siddiqui, et al.
Journal of Virology|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIV<sub>smE660</sub> Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesShakti Singh, Eric G Ramírez-Salazar, Rami Doueiri, et al.
The Journal of Pediatrics|September 24, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.
The Journal of Pediatrics|August 23, 2020
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune ResponsesLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Pageof 54